“…1,2 Its role in the identification, evaluation, and sampling of occult PD lesions that may not be visible by non-invasive imaging, transluminal endoscopic ultrasound (EUS), or pancreatography remains limited to case series. [3][4][5][6][7][8][9][10][11][12] The aims of this study are to: 1) evaluate the safety, efficacy, technical success, and adverse events of POP; and 2) determine the usefulness of POP for the differentiation of malignant from benign diseases of the pancreatic duct.…”